Skip to main content

Table 1 Field experiment A and B design. In experiment B, the study was conducted in two phases, in which the enrolled animals were split into two treatment groups across phase I or phase II

From: Field evaluation of the safety and compatibility of a combined vaccine against porcine parvovirus 1 and porcine reproductive and respiratory syndrome virus in breeding animals

 GroupNStudy day (SD)
Experiment A   072190
A-PRRSV+PPV1297Mixed vaccinea–––
A-PRRSV297PRRS MLV vaccineb–––
Experiment BPhase IBI-PRRSV+PPV1118Mixed vaccinePlacebocPPV1 subunit vaccinePRRS MLV vaccine
BI-PPV1120PPV1 subunit vaccinedPRRS MLV vaccinePPV1 subunit vaccinePRRS MLV vaccine
Phase II  201208298 
BII-PRRSV+PPV1138Mixed vaccinePlaceboPRRS MLV vaccine
BII-PPV1145PPV1 subunit vaccinePRRS MLV vaccinePRRS MLV vaccine
  1. aReproCyc® PRRS EU combined with ReproCyc® ParvoFLEX
  2. bReproCyc® PRRS EU
  3. cSodium chloride solution (NaCl; FisioVet®, B Braun VetCare, S.A., Rubí, Spain)
  4. dReproCyc® ParvoFLEX
Back to article page

Porcine Health Management

ISSN: 2055-5660

Contact us